2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Journal of Cancer Research and Clinical Oncology
•Research at a glance
Top areas of exploration
- Neoplasms , 8 publications
- Immune Checkpoint Inhibitors , 5 publications
- Immunotherapy , 5 publications
- Circulating Tumor DNA , 4 publications
Research activity
My publications
Filter publications
30 publications
2024
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients
ESMO Open
•2024
Low-Dose Anti-PD(L)1 for the Treatment of Solid Malignancies.
JCO global oncology
•2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)
Annals of Oncology
2023
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022
Annals of Oncology